Inventor · disambiguated record
Michael Jeffers
Also filed as: JEFFERS MICHAEL · JEFFERS MICHAEL E
8 granted patents·27 pending applications·78 citations·filing 2000–2018
86Inventor score
Top patents by PatentIndex Score
35 records- 0187US8067544B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2004·Granted Nov 29, 2011·37 cites·18 claims
- 0283US6982250B2Methods of prevention and treatment of inflammatory bowel diseaseCURAGEN CORP·Filed 2001·Granted Jan 3, 2006·9 cites·26 claims
- 0380US8846873B2Antibodies directed to GPNMB and uses thereofXIAO FENG·Filed 2012·Granted Sep 30, 2014·9 cites·27 claims
- 0477US6537554B1Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesisCURAGEN CORP·Filed 2000·Granted Mar 25, 2003·7 cites·4 claims
- 0574US7253266B2Polypeptides of FGF-CXCURAGEN CORP·Filed 2002·Granted Aug 7, 2007·5 cites·11 claims
- 0674US7189693B2Treatment of inflammatory bowel disease using fibroblast growth factor CX polypeptidesCURAGEN CORP·Filed 2002·Granted Mar 13, 2007·4 cites·26 claims
- 0773US7056885B1Fibroblast growth factor and nucleic acids encoding sameCURAGEN CORP·Filed 2000·Granted Jun 6, 2006·7 cites·6 claims
- 0866US2014314780A1Compositions Using Antibodies Directed to GPNMB and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 0961US2018043014A1Compositions Using Antibodies Directed to GPNMB and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1059US2013156784A1Compositions Using Antibodies Directed To GPNMB And Uses ThereofJEFFERS MICHAEL·Filed 2012·Application pending·0 cites
- 1155US2015044212A1Antibodies Directed to GPNMB and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1255US2005164929A1Methods of preventing and treating inflammatory bowel diseaseLUPINE LOGIC INC·Filed 2004·Application pending·0 cites
- 1353US2005208514A1Novel fibroblast growth factor and nucleic acids encoding dameALSOBROOK JOHN II·Filed 2004·Application pending·0 cites
- 1452US2005063971A1Antibodies to fibroblast growth factor and their methods of useCURAGEN CORP·Filed 2004·Application pending·0 cites
- 1552US2005256042A1Methods of preventing and treating alimentary mucositisJEFFERS MICHAEL E·Filed 2004·Application pending·0 cites
- 1651US2007178452A1Method for analyzing a nucleic acidBOUFFARD PASCAL·Filed 2002·Application pending·0 cites
- 1750US2017218067A1Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1849US9580503B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2011·Granted Feb 28, 2017·0 cites·16 claims
- 1949US2003104573A1Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesisFiled 2003·Application pending·0 cites
- 2048US2005256039A1Novel fibroblast growth factors and methods of use thereofPETERSON JEFFERY·Filed 2004·Application pending·0 cites
- 2148US2013058948A1Antibodies Directed To Gpnmb And Uses ThereofJEFFERS MICHAEL·Filed 2012·Application pending·0 cites
- 2247US2016280784A1Antibodies Directed to GPNMB and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2347US2016311919A1Antibodies Directed To GPNMB And Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2447US2013202527A1Method of Treating Ovarian and Renal Cancer Using Antibodies Against T Cell Immunoglobulin Domain And Mucin Domain 1 (TIM-1) AntigenCELLDEX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2544US2017267750A1Method of Treating Ovarian and Renal Cancer Using Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) AntigenCELLDEX THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2644US2008287349A1Fibroblast growth factor 20 and methods of use thereofPETERSON JEFFREY·Filed 2004·Application pending·0 cites
- 2744US2004029789A1Novel proteins and nucleic acids encoding sameFiled 2002·Application pending·0 cites
- 2843US2002058036A1Novel fibroblast growth factor and nucleic acids encoding sameFiled 2001·Application pending·0 cites
- 2943US2004018199A1Compositions and methods of use for an ephrin receptorFiled 2003·Application pending·0 cites
- 3042US2004023241A1Therapeutic polypeptides, nucleic acids encoding same, and methods of useFiled 2002·Application pending·0 cites
- 3140US2015267258A1Biomarkers for determining effective response of treatments of hepatocellular carcinoma (hcc) patientsBayer Pharma AG·Filed 2013·Application pending·0 cites
- 3240US2004214759A1Compositions and methods of use for a fibroblast growth factorFiled 2003·Application pending·0 cites
- 3338US2006094647A1Treatment of inflammatory bowel disease using growth factorsJEFFERS MICHAEL E·Filed 2001·Application pending·0 cites
- 3437US2002094546A1Growth factor polypeptides and nucleic acids encoding sameFiled 2001·Application pending·0 cites
- 3536US2021113598A1Combination of MIDH1 Inhibitors and DNA Hypomethylating Agents (HMA)DEUTSCHES KREBSFORSCHUNGSZENTRUM DKFZ STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Jeffers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →